New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Envoy Therapeutics
- 555 Heritage Drive
- Jupiter FL, 33458
- UNITED STATES
Envoy’s mission is to change drug discovery by advancing new drugs that act on targets expressed specifically in the cell populations important to diseases. Their goal is to bring forth drugs that help millions of people while causing fewer side effects. Envoy hopes to achieve this mission through their powerful technology, called “bacTRAP”, that allows them to measure, in vivo, the expression of each protein within any given cell type.